Mounjaro might be the next drug—after Ozempic—to upend the weight-loss market after a study showed it helped overweight and obese patients with Type 2 diabetes lose up to 15.7% of their body weight
Illustration: Elizabeth SmelovEli Lilly & Co.’s drug Mounjaro for Type 2 diabetes helped people who are also overweight or obese lose up to 15.
7% of their body weight, in a new study that could pave the way for Lilly to promote the drug asIndianapolis-based Lilly said that with the new data, it will complete in the coming weeks an application to the U.S. Food and Drug AdministrationContinue reading your article with
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Rival Ozempic Drug Helped Diabetes Patients Shed Up to 34 Pounds: TrialPharmaceutical giant Eli Lilly on Thursday made an announcement—not that insulin is free now, but that a different drug it makes helped obese, diabetic patients shed almost 16 percent of their body weight over nearly 17 months.
Read more »
Popular diabetes drug Mounjaro could be FDA-approved for weight loss this year, company saysA popular drug currently approved to treat Type 2 diabetes could soon also be approved for weight loss.
Read more »
Mounjaro Helps Diabetes Patients Lose ‘Meaningful’ Weight, Study ShowsMounjaro might be the next drug—after Ozempic—to upend the weight-loss market after a study showed it helped overweight and obese patients with Type 2 diabetes lose up to 15.7% of their body weight
Read more »
Eli Lilly Pushes For Fast-Track Approval Of Mounjaro As Weight-Loss DrugLate-stage trials suggest Lilly’s tirzepatide, sold under Mounjaro, could be a more effective obesity drug that Ozempic or Wegovy, and the company expects a regulatory decision by the end of the year.
Read more »
Mounjaro: Powerful new obesity drug poised to upend weight loss careEli Lily reported that the drug helped people with diabetes who were overweight or had obesity lose up to 16% of their body weight over 17 months in a late-stage trial.
Read more »
Mounjaro: Powerful new obesity drug poised to upend weight loss careEli Lily reported that the drug helped people with diabetes who were overweight or had obesity lose up to 16% of their body weight over 17 months in a late-stage trial.
Read more »